Zambon Company S.p.A. - Strategic SWOT Analysis Review

  • August 2014
  • -
  • Global Data
  • -
  • 26 pages

Zambon Company S.p.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Zambon Company S.p.A. (Zambon) is a manufacturer of pharmaceutical and fine chemical products. It operates its business through three major companies: Zambon S.p.A., ZaCh System S.p.A., and Zcube S.r.l. The company carries out its business through three divisions, namely; Pharmaceutical Business, Chemical Business and Industrial Incubator. Zambon’s pharmaceutical products include respiratory, pain management, and women’s healthcare products, and fine chemical products comprise custom synthesis and generic APIs. Its industrial incubator business division offers drug delivery technology concepts, which are used in the treatment of patients. The company has operations across Europe, North and South America, and Asia. It has manufacturing plants in Vicenza and Lonigo, Italy; Cadempina, Switzerland; Itaperica, Brazil; and Haikou, China. The company functions as the holding company of Zambon Group. Zambon is headquartered in Bresso, Italy.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2


Section 1 - About the Company 5
Zambon Company S.p.A. - Key Facts 5
Zambon Company S.p.A. - Key Employees 6
Zambon Company S.p.A. - Major Products and Services 7
Zambon Company S.p.A. - Pharmaceutical Pipeline Products Data 9
Zambon Company S.p.A., Pipeline Products by Therapy Area 9
Zambon Company S.p.A., Pipeline Products by Development Phase 10
Zambon Company S.p.A. - History 12
Zambon Company S.p.A. - Company Statement 14
Zambon Company S.p.A. - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 18
Zambon Company S.p.A. - Business Description 18
Zambon Company S.p.A. - SWOT Analysis 19
SWOT Analysis - Overview 19
Zambon Company S.p.A. - Strengths 19
Strength - Strong Product Portfolio 19
Strength - Organizational Framework 19
Strength - Manufacturing Capabilities 19
Zambon Company S.p.A. - Weaknesses 19
Weakness - Overdependence on Europe 19
Zambon Company S.p.A. - Opportunities 20
Opportunity - Emerging markets 20
Opportunity - Demographic Trends 20
Opportunity - Market Prospects -Asthma 20
Opportunity - Strategic Growth Initiatives 20
Zambon Company S.p.A. - Threats 21
Threat - Competition and Technological Changes 21
Threat - Failure of New Product in Clinical Trials 21
Threat - Stringent Government Regulations 21
Zambon Company S.p.A. - Key Competitors 22
Section 3 - Company’s Lifesciences Financial Deals and Alliances 23
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 23
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 24
Zambon Company S.p.A., Recent Deals Summary 25
Section 4 - Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Zambon Company S.p.A., Key Facts 5
Zambon Company S.p.A., Key Employees 6
Zambon Company S.p.A., Major Products and Services 7
Zambon Company S.p.A., Number of Pipeline Products by Therapy Area 9
Zambon Company S.p.A., Number of Pipeline Products by Development Stage 10
Zambon Company S.p.A., Pipeline Products By Therapy Area and Development Phase 11
Zambon Company S.p.A., History 12
Zambon Company S.p.A., Other Locations 15
Zambon Company S.p.A., Subsidiaries 16
Zambon Company S.p.A., Key Competitors 22
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 23
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 24
Zambon Company S.p.A., Recent Deals Summary 25

List of Figures
Zambon Company S.p.A., Pipeline Products by Therapy Area 9
Zambon Company S.p.A., Pipeline Products by Development Phase 10
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 23
Zambon Company S.p.A., Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 24

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

D. Medical Industries Limited (DMED) - Financial and Strategic SWOT Analysis Review

D. Medical Industries Limited (DMED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary D. Medical Industries Limited (D. Medical) is a medical device company. The company through its subsidiaries undertakes research and development, manufacture and sale of products for the treatment ...

Orient Pharma Co., Ltd. (4166) - Financial and Strategic SWOT Analysis Review

Orient Pharma Co., Ltd. (4166) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Orient PHARMA Co., Ltd. (Oripharm) is a pharmaceutical company. The company manufactures and distributes pharmaceuticals. Its drug delivery technologies include multi-stages controlled release ...

Plant Bioscience Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Plant Bioscience Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Plant Bioscience Limited (PBL) is a technology company. The company provides IP management, patent advisory and technology transfer services to life science companies and investors. It also offers ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.